FindTrial
Sign In

Resolute Integrity Stent

DEVICE6 trials

Sponsors

Medtronic Vascular, The University of Hong Kong, Emory University, Stanford University, UMC Utrecht

Conditions

Acute Coronary SyndromeCoronary Artery DiseaseCoronary DiseaseCoronary StenosisStable Angina Pectoris

Phase 4

A Study Comparing Two Stent on the Degree of Early Stent Healing and Late Lumen Loss.The OCT-ORION Study
CompletedNCT01742507
The University of Hong KongCoronary Artery Disease
Start: 2012-04-30End: 2016-08-31Updated: 2017-07-26
Randomized All-comer Evaluation of a Permanent Polymer Resolute Integrity Stent Versus a Polymer Free Cre8 Stent
NCT02328898
UMC UtrechtAcute Coronary Syndrome, Stable Angina Pectoris
Start: 2014-11-30End: 2020-09-30Target: 1532Updated: 2018-04-25

Unknown Phase

An Evaluation of the Commercially Available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent System
CompletedNCT01638507
Medtronic VascularCoronary Artery Disease
Start: 2012-07-31End: 2015-06-30Updated: 2019-04-03
Optical Frequency Domain Imaging (OFDI) and Vascular Healing After Stent Placement
CompletedNCT01794949
Emory UniversityCoronary Artery Disease
Start: 2013-09-30End: 2016-11-30Updated: 2017-05-15
Resolute Integrity US Extended Length Sub-Study(RI US XL)
CompletedNCT01913600
Medtronic VascularCoronary Artery Disease
Start: 2013-07-31End: 2018-12-31Updated: 2019-05-08
A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
CompletedNCT02100722
Stanford UniversityCoronary Disease, Coronary Stenosis
Start: 2014-08-25End: 2024-12-01Updated: 2026-04-07

Related Papers

Outcomes After CABG Compared With FFR-Guided PCI in Patients Presenting With Acute Coronary Syndrome.
2025-04-012 citations
Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial.
2025-03-3014 citations
FFR-Guided Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Diabetes
JAMA Cardiology2025-03-123 citations
Sex Differences in Patients Undergoing FFR-Guided PCI or CABG in the FAME 3 Trial.
2024-12-041 citations
Impact of a Chronic Total Occlusion on Outcomes After FFR-Guided PCI or Coronary Bypass Surgery: A FAME 3 Substudy
Circulation Cardiovascular Interventions2024-11-011 citations
Fractional Flow Reserve–Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial
Circulation2023-08-2155 citations
High bleeding risk in patients undergoing percutaneous coronary intervention with drug-eluting stent implantation: ReCre8 subanalysis.
2022-11-091 citations
Prognostic Value of Measuring Fractional Flow Reserve After Percutaneous Coronary Intervention in Patients With Complex Coronary Artery Disease: Insights From the FAME 3 Trial
Circulation Cardiovascular Interventions2022-09-1915 citations
Quality of Life After Fractional Flow Reserve–Guided PCI Compared With Coronary Bypass Surgery
Circulation2022-04-0214 citations
Fractional Flow Reserve–Guided PCI as Compared with Coronary Bypass Surgery
New England Journal of Medicine2021-11-04322 citations
3-Year Clinical Outcomes After Implantation of Permanent-Polymer Versus Polymer-Free Stent: ReCre8 Landmark Analysis.
2021-11-0115 citations
Randomized All-Comers Evaluation of a Permanent Polymer Zotarolimus-Eluting Stent Versus a Polymer-Free Amphilimus-Eluting Stent
Circulation2018-12-2839 citations
The OCT-ORION Study
Circulation Cardiovascular Interventions2018-04-0116 citations
Rationale and design of amphilimus sirolimus‐eluting stents versus zotarolimus‐eluting stents in all‐comers requiring percutaneous coronary intervention (ReCre8): A multicenter randomized clinical trial
Catheterization and Cardiovascular Interventions2017-05-2210 citations